patient
manifestationconvalesc
period
postinfect
period
serum
sampl
collect
hospit
sar
patient
within
week
onset
ill
set
sequenti
sampl
patient
month
recoveri
set
postinfect
sampl
subject
serum
sampl
healthi
blood
donor
set
collect
also
includ
specif
igg
respons
whole
viru
fragment
posit
protein
fulllength
n
protein
sarscov
measur
enzymelink
immunosorb
assay
elisa
western
blot
assay
carri
confirm
elisa
result
fiftyon
serum
sampl
set
bound
n
protein
proport
similar
recogn
whole
viru
sprotein
fragment
serum
sampl
set
strongli
posit
nproteinspecif
igg
posit
igg
two
serum
sampl
set
strongli
posit
antinprotein
igg
igg
similar
level
igg
respons
n
protein
observ
sar
patient
manifest
convalesc
stage
postinfect
period
howev
number
patient
much
lower
serum
igg
level
n
protein
sever
acut
respiratori
syndrom
sar
associ
coronaviru
sarscov
positivestrand
rna
viru
famili
coronavirida
caus
agent
sar
genom
encod
sever
structur
nonstructur
protein
includ
spike
glycoprotein
nucleocapsid
n
protein
membran
protein
rna
polymeras
main
proteas
protein
n
protein
sarscov
share
homolog
n
protein
human
cov
strain
abundantli
express
cell
infect
sarscov
induc
strong
antibodi
respons
patient
glycoprotein
mediat
membran
fusion
viru
host
cell
consist
amino
acid
residu
approxim
homolog
glycoprotein
human
cov
previous
document
fragment
compris
amino
acid
residu
protein
sarscov
contain
immunodomin
epitop
use
high
specif
sensit
coat
antigen
enzymelink
immunosorb
assay
elisa
detect
antisprotein
immunoglobulin
g
igg
patient
sera
howev
level
igg
antibodi
n
protein
serum
postinfect
period
sar
patient
fulli
character
studi
use
recombin
protein
antigen
elisa
system
compar
serum
igg
respons
n
protein
sarscov
manifestationconvalesc
period
postinfect
period
sar
patient
serum
sampl
six
patient
confirm
sar
secondor
thirdgener
case
admit
ditan
hospit
april
june
therefor
also
includ
set
infect
includ
studi
confirm
presenc
igg
antibodi
sarscov
use
huada
elisa
kit
see
inform
consent
obtain
patient
blood
collect
sera
set
patient
recov
sar
collect
juli
august
month
recoveri
subsequ
discharg
hospit
beij
red
cross
blood
center
blood
sampl
process
within
h
collect
sera
store
set
compris
serum
sampl
healthi
blood
donor
sex
age
rang
year
collect
may
juli
also
provid
beij
red
cross
blood
center
addit
control
serum
sampl
pool
healthi
donor
sera
hd
prepar
mix
sera
randomli
select
healthi
individu
use
throughout
studi
express
purif
recombin
protein
construct
express
plasmid
sprotein
fragment
method
use
subsequ
express
describ
previous
dna
encod
fulllength
n
protein
clone
vector
novagen
recombin
histag
fusion
protein
express
e
coli
briefli
bacteri
coloni
harbor
plasmid
cultur
appropri
densiti
yeast
extracttrypton
medium
contain
kanamycin
gml
continu
shake
ad
induc
express
fusion
protein
h
incub
bacteri
cell
suspens
centrifug
g
min
cell
pellet
resuspend
subject
sonic
ice
bath
min
lyse
cell
centrifug
g
min
supernat
subsequ
appli
ni
column
columnbound
protein
elut
elut
buffer
contain
mm
imidazol
examin
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
stain
coomassi
blue
transfer
nitrocellulos
membran
western
blot
western
blot
assay
nitrocellulos
membran
pierc
rockford
il
recombin
protein
transfer
block
room
temperatur
h
nonfat
dri
milk
trisbuff
salin
tb
ph
incub
serum
sampl
h
room
temperatur
membran
wash
tb
contain
tween
incub
hrplabel
goat
antihuman
igg
reaction
visual
use
substrat
tetrahydrochlorid
sigma
st
loui
mo
elisa
elisa
plate
coat
overnight
recombin
protein
pmolwel
carbon
buffer
ph
well
plate
incub
block
solut
bovin
serum
albumin
phosphatebuff
salin
pb
h
well
wash
five
time
pb
contain
tween
pbst
one
hundr
microlit
serial
dilut
sera
human
igg
ad
triplic
follow
incub
min
five
wash
pbst
plate
incub
hrplabel
goat
antihuman
igg
antibodi
h
orthophenylenediamin
lwell
sigma
ad
five
wash
pbst
well
incub
min
room
temperatur
fifti
microlit
h
ad
well
termin
reaction
optic
densiti
od
immedi
read
nm
sarscovspecif
elisa
kit
develop
huada
institut
china
wide
use
china
sarscovspecif
antibodi
test
reliabl
result
elisa
kit
produc
huada
institut
manufactur
instruct
follow
briefli
dilut
buffer
lwell
ad
precoat
well
follow
addit
l
serum
incub
min
wash
hrplabel
detect
antibodi
dilut
ad
lwell
plate
incub
min
wash
substrat
buffer
contain
sulfon
ad
reaction
allow
develop
min
stop
buffer
ad
plate
read
nm
prepar
pseudoviru
pseudoviru
express
sarscov
protein
prepar
describ
previous
briefli
cell
maintain
dulbecco
modifi
eagl
medium
contain
fetal
calf
serum
seed
tissu
cultur
dish
one
day
later
cell
cotransfect
defect
human
immunodefici
viru
type
genom
e
g
either
plasmid
pvsvg
g
encod
vesicular
stomat
viru
vsv
g
protein
plasmid
pcmv
encod
protein
sarscov
use
transfect
reagent
vigor
biotech
co
beij
china
defect
genom
contain
gene
luciferas
use
report
success
infect
pseudoviru
cultur
medium
replac
fresh
medium
h
posttransfect
cell
cultur
addit
h
cultur
supernat
contain
vsv
gproteinexpress
vsvg
pseudoviru
sarscov
sproteinexpress
sarscov
pseudoviru
harvest
filter
filter
follow
centrifug
rpm
h
ultracentrifug
beckman
coulter
fullerton
ca
pseudovir
pellet
resuspend
pb
titrat
aliquot
store
use
neutral
assay
sarscov
pseudoviru
system
sarscov
pseudoviru
vsvg
pseudoviru
infect
cell
neutral
infect
describ
previous
briefli
vero
cell
maintain
dulbecco
modifi
eagl
medium
contain
fetal
calf
serum
seed
plate
densiti
cellswel
cultur
overnight
serial
dilut
serum
sampl
mix
pseudoviru
prepar
min
mixtur
ad
well
contain
monolay
vero
cell
incub
h
mixtur
well
replac
fresh
medium
cell
cultur
addit
h
wash
cell
lyse
luciferas
assay
reagent
promega
madison
wi
luciferas
activ
cell
lysat
determin
verita
micropl
luminomet
turner
biosystem
luciferas
activ
refer
group
vero
cell
treat
pseudoviru
alon
taken
infect
cell
treat
pseudoviru
includ
specif
control
luciferas
activ
read
least
log
unit
lower
refer
group
experi
luciferas
activ
experiment
group
vero
cell
treat
pseudoviru
prepar
presenc
serum
antibodi
compar
refer
group
result
express
percent
infect
calcul
follow
luciferas
activ
experiment
groupsluciferas
activ
refer
group
statist
analysi
experi
describ
carri
least
three
time
result
obtain
nand
sbase
elisa
huada
elisa
kit
compar
use
correl
modul
microsoft
excel
softwar
cohen
kappa
test
perform
analyz
agreement
result
obtain
elisa
kit
comparison
data
perform
student
test
signific
defin
p
valu
march
guest
http
cviasmorg
recombin
sprotein
fragment
kda
fulllength
n
protein
kda
express
e
coli
purifi
puriti
determin
sdspage
analysi
fig
antigen
confirm
western
blot
assay
fig
recombin
protein
use
coat
antigen
develop
elisa
system
detect
sspecif
nspecif
antibodi
result
present
fig
demonstr
elisa
system
abl
readili
detect
specif
igg
antibodi
patient
sera
confirm
assay
specif
individu
serum
sampl
healthi
blood
donor
set
screen
dilut
nproteinbas
elisa
none
posit
elisa
fig
interestingli
serum
sampl
posit
nproteinbas
elisa
fig
subsequ
confirm
result
western
blot
assay
see
serum
sampl
remain
posit
nproteinbas
also
huada
elisa
even
dilut
data
shown
nproteinspecif
igg
antibodi
patient
sera
n
proteinbas
elisa
exhibit
better
sensit
virusbas
kit
analyz
sera
set
illustr
fig
tabl
serum
sampl
set
posit
antinprotein
igg
antibodi
serum
sampl
posit
huada
test
fig
tabl
serum
sampl
set
strongli
posit
antinprotein
igg
antibodi
consist
result
huada
elisa
fig
b
tabl
nproteinbas
virusbas
elisa
data
plot
close
linear
correl
firstdegre
regress
r
observ
fig
cohen
kappa
test
also
confirm
strong
agreement
result
obtain
two
elisa
system
antisprotein
igg
antibodi
patient
sera
serum
sampl
set
posit
elisa
slightli
less
proport
posit
virusbas
nproteinbas
tabl
differ
pattern
antisprotein
antinprotein
igg
profil
observ
sar
patient
exampl
patient
strong
respond
protein
rel
weak
respond
n
protein
contrast
patient
strong
respond
n
protein
nonrespond
sprotein
fragment
fig
c
serum
sampl
set
posit
elisa
fig
tabl
cohen
kappa
test
confirm
correl
sproteinbas
nproteinbas
elisa
firstdegre
regress
r
sproteinbas
wholevirusbas
elisa
firstdegre
regress
r
fig
c
repres
serum
sampl
includ
serum
sampl
strong
serum
sampl
medium
serum
sampl
weak
neg
serum
sampl
respond
determin
elisa
fig
analyz
abil
recogn
recombin
n
protein
western
blot
assay
fig
result
consist
obtain
nproteinbas
elisa
although
western
blot
appear
less
sensit
detect
sproteinspecif
antibodi
instanc
sampl
weakli
posit
elisa
unabl
recogn
western
blot
fig
serum
sampl
healthi
donor
also
assay
abil
recogn
recombin
n
protein
western
blot
clearli
react
n
protein
fragment
fig
consist
data
shown
fig
serum
sampl
set
collect
earli
phase
infect
allow
us
assess
kinet
antivir
igg
respons
vivo
illustr
fig
specif
igg
antibodi
detect
nbase
fig
fig
elisa
earli
day
onset
ill
day
earlier
time
detect
whole
virusbas
kit
fig
correl
antibodi
titer
neutral
abil
serum
sampl
cotransfect
cell
sarscov
sproteinexpress
vector
defect
genom
express
luciferas
prepar
protein
express
pseudoviru
pseudoviru
thu
obtain
abl
infect
angiotensinconvert
enzym
posit
vero
cell
vitro
known
receptor
sarscov
system
use
test
neutral
capac
serum
sampl
shown
fig
serum
sampl
respond
fragment
serum
sampl
could
dramat
block
sarscov
pseudoviru
infect
vero
cell
weak
respond
serum
sampl
sampl
much
less
effici
serum
sampl
two
healthi
blood
donor
serum
sampl
react
fragment
show
neutral
abil
fig
whole
virusbas
elisa
advantag
abl
detect
antibodi
specif
structur
compon
viru
howev
proteinbas
assay
permit
detail
analysi
antivir
humor
respons
nproteinbas
sproteinbas
elisa
system
appear
sensit
virusbas
huada
elisa
kit
sinc
sera
dilut
instead
use
proteinbas
assay
sever
group
report
n
protein
immunodomin
antigen
sarscov
capabl
induc
strong
antibodi
respons
human
studi
close
correl
nproteinbas
virusbas
elisa
result
clearli
establish
fig
sinc
polypeptid
cover
less
onefifth
sprotein
sequenc
neg
result
assay
necessarili
rule
possibl
presenc
antisprotein
antibodi
sampl
investig
howev
ampl
evid
suggest
contain
domin
epitop
antisprotein
antibodi
sera
patient
confirm
sar
instanc
previous
shown
elisa
could
detect
igg
antibodi
specif
two
immunodomin
bcell
epitop
convalescentphas
sera
sar
patient
sensit
specif
fashion
lu
cowork
show
patient
sera
mainli
recogn
epitop
contain
within
residu
protein
sarscov
determin
western
blot
assay
addit
zhou
colleagu
document
residu
protein
sarscov
elicit
neutral
antibodi
viru
comparison
antinprotein
antisprotein
tabl
suggest
antibodi
structur
protein
success
induc
soon
infect
howev
clear
segreg
antinprotein
antisprotein
igg
level
observ
postinfect
sera
rate
posit
antisprotein
antibodi
lower
antinprotein
antibodi
versu
posit
antinprotein
antisprotein
igg
respect
observ
may
import
implic
understand
humor
immun
sarscov
also
futur
sar
vaccin
program
exampl
combin
prime
inactiv
viru
vaccin
boost
recombin
protein
may
necessari
maintain
hightit
sproteinspecif
neutral
antibodi
recipi
sarscov
bind
receptor
cell
surfac
use
protein
thu
sproteinspecif
rather
nproteinspecif
antibodi
abl
neutral
infecfig
western
blot
assay
sera
patient
healthi
subject
recombin
n
protein
lane
n
lane
protein
lane
run
polyacrylamid
gel
electrophoresi
protein
band
transfer
onto
nitrocellulos
membran
probe
sera
patient
convalesc
phase
set
c
serum
sampl
healthi
blood
donor
set
bound
antibodi
detect
use
hrplabel
goat
antihuman
igg
data
fig
indic
posit
correl
titer
igg
antibodi
neutral
abil
even
though
number
serum
sampl
n
includ
small
statist
meaning
analysi
correl
antibodi
titer
neutral
activ
result
nonetheless
support
notion
presum
individu
make
neutral
antibodi
follow
sarscov
infect
howev
sproteinspecif
neutral
antibodi
seem
last
host
rel
shorter
period
time
nproteinspecif
antibodi
evidenc
clear
segreg
antinprotein
antisprotein
igg
antibodi
serum
sampl
set
two
serum
sampl
set
strongli
posit
nproteinbas
elisa
western
blot
assay
fig
also
huada
elisa
tabl
epidemiolog
intrigu
serum
sampl
collect
year
first
report
outbreak
sar
human
two
individu
recal
mild
infect
symptom
similar
associ
sar
prior
blood
sampl
collect
studi
also
illustr
nproteinspecif
sera
neutral
abil
pseudoviru
neutral
assay
fig
possibl
antibodi
elicit
sera
individu
infect
human
cov
strain
document
human
cov
strain
respons
common
cold
recent
identifi
strain
also
contribut
significantli
overal
spectrum
cov
infect
n
protein
known
cov
rel
conserv
structur
protein
n
protein
human
cov
strain
share
highest
amino
acid
sequenc
ident
human
cov
strain
n
protein
human
cov
strain
less
homolog
nongroup
cov
furthermor
sun
meng
show
polyclon
antisera
known
anim
cov
crossreact
n
protein
sarscov
sinc
serolog
remain
gold
standard
diagnosi
sar
import
explor
serolog
crossreact
sarscov
cov
